Market Overview:
The global digital pathology systems market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for diagnostic services, technological advancements, and rising prevalence of diseases. The global digital pathology systems market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into static telepathology, dynamic telepathology, and hybrid telepathology. Static telepathology accounted for a major share of the global digital pathology systems market in 2017 owing to its low cost and easy installation as compared to other types of digital pathology systems.
Product Definition:
Digital pathology systems are used to store, manage and share digital images of tissues and cells. They are important because they allow for more accurate diagnosis of diseases, faster research and improved patient care.
Static Telepathology:
Static telepathology is the practice of using a video camera and some type of monitor to observe the activities of a dead body. The main purpose is to examine whether or not there are any symptoms, which can provide information about disease processes in its early stages.
The growth factor for static telepathology market includes rising awareness among healthcare professionals regarding advanced diagnostic tools, increasing demand for cost-effective diagnosis & treatment options along with technological advancements such as high definition monitors.
Dynamic Telepathology:
Dynamic telepathology is a new term in the digital pathology world. It was created to differentiate between the regular practice of medical science and its application in digital pathology. The main objective of this technique is to provide real-time consultation and diagnosis over a distance using information technology, specifically video conferencing software programs or telemedicine systems.
Application Insights:
The disease diagnosis segment dominated the global digital pathology systems market in 2017. This can be attributed to an increase in demand for rapid and accurate diagnoses of diseases, such as cancer. The academic research segment is expected to witness lucrative growth over the forecast period due to increasing investments by companies and research institutions for advanced diagnostic technologies. For instance, In November 2016, Siemens launched a new system - Aios Pro for pathologists at major medical centers who need enhanced productivity while working with large volumes of tumor samples.
Digital pathology systems have also been used extensively in drug discovery & development applications across various industries such as pharmaceuticals and biotechnology. These systems provide researchers with a virtual window into cellular processes that enable them to observe molecular events more closely than ever before (see here).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as local presence of major players, high adoption rate of advanced technologies and a large number of research projects being undertaken by industry players for the development of digital pathology systems. Asia Pacific is expected to grow at a lucrative CAGR over the forecast period owing to increasing government initiatives pertaining to improving healthcare infrastructure and rising awareness about early disease diagnosis. Moreover, an increase in outsourcing activities by various companies will also drive growth during the forecast period.
Growth Factors:
- Increasing demand for minimally invasive diagnostic procedures: The global market for minimally invasive diagnostic procedures is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is primarily due to the increasing incidence of cancer and other chronic diseases, technological advancements in the field of diagnostics, and rising healthcare expenditure. Digital pathology systems are increasingly being used for such procedures as they offer several advantages over traditional methods such as histology or immunohistochemistry (IHC). These systems provide high-resolution images that help in accurate diagnosis, allow remote consultation by experts, and facilitate faster turnaround time for results.
- Growing demand for personalized medicine: The global market for personalized medicine is expected to grow at a CAGR of 16% from 2016 to 2021. This growth can be attributed to the increasing prevalence of chronic diseases, growing awareness about the benefits of personalized medicine among patients and healthcare professionals, and technological advancements in this field. Digital pathology systems play an important role in providing customized treatment plans based on an individual’s genetic profile or disease characteristics. They help improve patient outcomes by allowing physicians to make better decisions about treatment options using detailed information about the patient’s disease state.
Scope Of The Report
Report Attributes
Report Details
Report Title
Digital Pathology Systems Market Research Report
By Type
Static Telepathology, Dynamic Telepathology, Hybrid Telepathology
By Application
Disease Diagnosis, Academic Research, Drug Discovery and Development
By Companies
3Dhistech Ltd (Hungary), Apollo Enterprise Imaging Corp (USA), Carl Zeiss AG (Germany), Corista LLC (USA), Definiens AG (Germany), Hamamatsu Photonics K.K. (Japan), Huron Digital Pathology, Inc (Canada), Leica Biosystems Nussloch GmbH (Germany), MikroScan Technologies, Inc (USA), Olympus Corporation (Japan), Philips Healthcare (Netherlands), Pixcelldata Ltd. (Ireland), Roche(Ventana Medical Systems), VMscope GmbH (Germany)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Digital Pathology Systems Market Report Segments:
The global Digital Pathology Systems market is segmented on the basis of:
Types
Static Telepathology, Dynamic Telepathology, Hybrid Telepathology
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Disease Diagnosis, Academic Research, Drug Discovery and Development
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3Dhistech Ltd (Hungary)
- Apollo Enterprise Imaging Corp (USA)
- Carl Zeiss AG (Germany)
- Corista LLC (USA)
- Definiens AG (Germany)
- Hamamatsu Photonics K.K. (Japan)
- Huron Digital Pathology, Inc (Canada)
- Leica Biosystems Nussloch GmbH (Germany)
- MikroScan Technologies, Inc (USA)
- Olympus Corporation (Japan)
- Philips Healthcare (Netherlands)
- Pixcelldata Ltd. (Ireland)
- Roche(Ventana Medical Systems)
- VMscope GmbH (Germany)
Highlights of The Digital Pathology Systems Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Static Telepathology
- Dynamic Telepathology
- Hybrid Telepathology
- By Application:
- Disease Diagnosis
- Academic Research
- Drug Discovery and Development
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Digital Pathology Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Digital pathology systems are a type of medical imaging technology that can be used to visualize and analyze the structure and function of tissues in vivo. These systems typically include a camera, computer, and storage device, which allows physicians to view images of tissue specimens captured using magnetic resonance or computed tomography (CT) scans. Digital pathology systems may also allow for the analysis of histopathology slides or other tissue samples.
Some of the major companies in the digital pathology systems market are 3Dhistech Ltd (Hungary), Apollo Enterprise Imaging Corp (USA), Carl Zeiss AG (Germany), Corista LLC (USA), Definiens AG (Germany), Hamamatsu Photonics K.K. (Japan), Huron Digital Pathology, Inc (Canada), Leica Biosystems Nussloch GmbH (Germany), MikroScan Technologies, Inc (USA), Olympus Corporation (Japan), Philips Healthcare (Netherlands), Pixcelldata Ltd. (Ireland), Roche(Ventana Medical Systems), VMscope GmbH (Germany).
The digital pathology systems market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Digital Pathology Systems Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Digital Pathology Systems Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Digital Pathology Systems Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Digital Pathology Systems Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Digital Pathology Systems Market Size & Forecast, 2018-2028
4.5.1 Digital Pathology Systems Market Size and Y-o-Y Growth
4.5.2 Digital Pathology Systems Market Absolute $ Opportunity
Chapter 5 Global Digital Pathology Systems Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Digital Pathology Systems Market Size Forecast by Type
5.2.1 Static Telepathology
5.2.2 Dynamic Telepathology
5.2.3 Hybrid Telepathology
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Digital Pathology Systems Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Digital Pathology Systems Market Size Forecast by Applications
6.2.1 Disease Diagnosis
6.2.2 Academic Research
6.2.3 Drug Discovery and Development
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Digital Pathology Systems Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Digital Pathology Systems Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Digital Pathology Systems Analysis and Forecast
9.1 Introduction
9.2 North America Digital Pathology Systems Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Digital Pathology Systems Market Size Forecast by Type
9.6.1 Static Telepathology
9.6.2 Dynamic Telepathology
9.6.3 Hybrid Telepathology
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Digital Pathology Systems Market Size Forecast by Applications
9.10.1 Disease Diagnosis
9.10.2 Academic Research
9.10.3 Drug Discovery and Development
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Digital Pathology Systems Analysis and Forecast
10.1 Introduction
10.2 Europe Digital Pathology Systems Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Digital Pathology Systems Market Size Forecast by Type
10.6.1 Static Telepathology
10.6.2 Dynamic Telepathology
10.6.3 Hybrid Telepathology
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Digital Pathology Systems Market Size Forecast by Applications
10.10.1 Disease Diagnosis
10.10.2 Academic Research
10.10.3 Drug Discovery and Development
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Digital Pathology Systems Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Digital Pathology Systems Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Digital Pathology Systems Market Size Forecast by Type
11.6.1 Static Telepathology
11.6.2 Dynamic Telepathology
11.6.3 Hybrid Telepathology
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Digital Pathology Systems Market Size Forecast by Applications
11.10.1 Disease Diagnosis
11.10.2 Academic Research
11.10.3 Drug Discovery and Development
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Digital Pathology Systems Analysis and Forecast
12.1 Introduction
12.2 Latin America Digital Pathology Systems Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Digital Pathology Systems Market Size Forecast by Type
12.6.1 Static Telepathology
12.6.2 Dynamic Telepathology
12.6.3 Hybrid Telepathology
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Digital Pathology Systems Market Size Forecast by Applications
12.10.1 Disease Diagnosis
12.10.2 Academic Research
12.10.3 Drug Discovery and Development
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Digital Pathology Systems Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Digital Pathology Systems Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Digital Pathology Systems Market Size Forecast by Type
13.6.1 Static Telepathology
13.6.2 Dynamic Telepathology
13.6.3 Hybrid Telepathology
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Digital Pathology Systems Market Size Forecast by Applications
13.10.1 Disease Diagnosis
13.10.2 Academic Research
13.10.3 Drug Discovery and Development
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Digital Pathology Systems Market: Competitive Dashboard
14.2 Global Digital Pathology Systems Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 3Dhistech Ltd (Hungary)
14.3.2 Apollo Enterprise Imaging Corp (USA)
14.3.3 Carl Zeiss AG (Germany)
14.3.4 Corista LLC (USA)
14.3.5 Definiens AG (Germany)
14.3.6 Hamamatsu Photonics K.K. (Japan)
14.3.7 Huron Digital Pathology, Inc (Canada)
14.3.8 Leica Biosystems Nussloch GmbH (Germany)
14.3.9 MikroScan Technologies, Inc (USA)
14.3.10 Olympus Corporation (Japan)
14.3.11 Philips Healthcare (Netherlands)
14.3.12 Pixcelldata Ltd. (Ireland)
14.3.13 Roche(Ventana Medical Systems)
14.3.14 VMscope GmbH (Germany)
